Lupin launches fixed dose inhaler drug for managing COPD, following approval from DGCIAbizar AttariOctober 6, 2026 Mumbai, October 6: Global pharmaceutical major Lupin Limited has launched Formoflo-G MDI, a novel fixed-dose triple combination metered-dose inhaler (MDI)…
